Peptides DB
Research-centric peptide and protocol reference hub

BPC-157 vs GHK-Cu

Updated September 21, 2026 · Reviewed by the PeptidesDB Editorial team

BPC-157: Research use — not FDA-approvedGHK-Cu: Research use — not FDA-approved

A data-driven comparison of BPC-157 and GHK-Cu (also searched as GHK-Cu vs BPC-157) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

BPC-157 centers on healing, while GHK-Cu leans toward skin. On indexed research, GHK-Cu is ahead (BPC-157: 14 studies, Human evidence; GHK-Cu: 24, Preclinical). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • BPC-157 is strongest for healing; GHK-Cu for skin.
  • Evidence: BPC-157 Human evidence (14 studies) vs GHK-Cu Preclinical (24).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

BPC-157GHK-Cu

At a glance

BPC-157Human evidence

Angiogenesis | Soft tissue repair

Strongest: HealingStudies: 14Level: Preclinical
GHK-CuPreclinical

Copper-binding | Wound healing

Strongest: SkinStudies: 24Level: Preclinical

BPC-157 vs GHK-Cu: side-by-side

MetricBPC-157GHK-Cu
ClassHealingHealing
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman evidencePreclinical
Studies indexed1424
Research levelPreclinicalPreclinical
Strongest effectHealing & recoverySkin & aesthetics
Healing & recovery4.04.0
Muscle & body comp3.01.0
Metabolic & appetite2.02.0
Neuro & mood2.03.0
Sleep & circadian1.01.0
Inflammation & immune4.04.0
Skin & aesthetics1.05.0

▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).

Mechanism & pharmacokinetics

PropertyBPC-157GHK-Cu
MechanismBody-protective compound (pentadecapeptide); cytoprotective, pro-angiogenic signalingCopper-binding tripeptide (GHK-Cu); tissue-remodeling / regenerative signaling
RouteSubcutaneous / oral (research use)Topical / subcutaneous

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is BPC-157?

Body Protective Compound often discussed for soft-tissue repair, GI support, and inflammation modulation.

Full BPC-157 profile, mechanism & studies →

What is GHK-Cu?

Copper-binding tripeptide widely used in skin, hair, and wound-healing contexts, with systemic effects explored in research.

Full GHK-Cu profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingEvenBoth ~4.0/5
MuscleBPC-1573.0/5 effect signal
MetabolicEvenBoth ~2.0/5
NeuroGHK-Cu3.0/5 effect signal
SleepEvenBoth ~1.0/5
InflammationEvenBoth ~4.0/5
SkinGHK-Cu5.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack BPC-157 and GHK-Cu?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

BPC-157 vs GHK-Cu: side effects

BPC-157

No community-reported effects logged yet.

GHK-Cu

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

BPC-157 has 14 approved studies indexed (Human evidence), and GHK-Cu has 24 (Preclinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is BPC-157 or GHK-Cu better?

It depends on your goal. BPC-157 is strongest for healing; GHK-Cu for skin. GHK-Cu has more indexed studies (24). See the goal-by-goal breakdown above.

Is BPC-157 or GHK-Cu better for weight loss?

They score similarly on the metabolic/appetite axis in the community data.

Is BPC-157 or GHK-Cu better for muscle?

BPC-157 leads on the muscle & body-composition axis (3.0/5).

Which has more research, BPC-157 or GHK-Cu?

BPC-157 has 14 approved studies indexed (Human evidence); GHK-Cu has 24 (Preclinical). Higher counts mean more to read, not proven superiority.

Can you stack BPC-157 and GHK-Cu?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of BPC-157 vs GHK-Cu?

BPC-157: no community-reported effects logged yet. GHK-Cu: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is BPC-157 or GHK-Cu FDA-approved?

BPC-157 is a research-use compound and is not FDA-approved. GHK-Cu is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is GHK-Cu better than BPC-157?

For skin, GHK-Cu has the edge; for healing, BPC-157 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

BPC-157 and GHK-Cu are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed September 21, 2026.